Cizzle Biotechnology
Business Services · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
60 Gracechurch St Fl 6, London, Greater ...Phone Number
+44 1904435112Website
www.cizzlebiotechnology.comRevenue
<$5 MillionStock Symbol
CIZIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Cizzle Biotechnology
Cizzle Biotech is focused on developing a cost-effective and non-invasive blood test for the early detection of lung cancer, utilizing their proprietary CIZ1B biomarker technology. Their innovative solution aims to reduce reliance on CT scans, which often lead to false positives and unnecessary procedures. The company targets healthcare professionals and patients, empowering them with a reliable diagnostic tool that enhances treatment options and improves survival rates. Cizzle Biotech is committed to transforming lung cancer care and making early detection accessible to everyone.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cizzle Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Cizzle Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Click to see if Cizzle Biotechnology had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Cizzle Biotechnology has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Cizzle Biotechnology launches new products
Check out if Cizzle Biotechnology is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Cizzle Biotechnology
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Cizzle Biotechnology recently announced quarterly report
Cizzle Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Cizzle Biotechnology
Compare insights from companies similar to Cizzle Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cizzle Biotechnology
<$5M
1-10
Public
<$5M
2006
N/A
Company Profile Activity
Activity Insights
Cizzle Biotechnology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cizzle Biotechnology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cizzle Biotechnology.
Cizzle Biotechnology financials insights
Gather financial insights about Cizzle Biotechnology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Unspecified
$1.1M
Cizzle Biotechnology Tech Stack
A closer look at the technologies used by Cizzle Biotechnology
See more technologies
Cizzle Biotechnology News & Media
CIZZLE BIOTECHNOLOGY ANNOUNCES GROUNDBREAKING COLLABORATION WITH MOFFITT CANCER CENTER TO ADVANCE EARLY-STAGE LUNG CANCER DETECTION
LONDON , Sept. 12, 2024 /PRNewswire/ -- Cizzle Biotechnology Holdings plc ("Cizzle"), a UK-based diagnostics company specialising in early-stage lung cancer detection, announces a pivotal collaboration with Moffitt Cancer Center, Florida's leading cancer hospital. This partnership will...Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western™ Platform
LONDON and MINNEAPOLIS, Sept. 19, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and Cizzle Biotechnology Holdings plc, the UK-based diagnostics developer, are pleased to announce recent progress evaluating specific monoclonal antibodies for Cizzle's CIZ1B cancer biomarker....Institutional investors own a significant stake of 50% in Cizzle Biotechnology Holdings Plc (LON:CIZ)
If you want to know who really controls Cizzle Biotechnology Holdings Plc ( LON:CIZ ), then you'll have to look at the...York based Cizzle secures £1 million for cancer research
A YORK based firm developing revolutionary new methods of diagnosing and treating lung cancer has been given a huge cash injection.
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Cizzle Biotechnology
Sign Up For FreeTo access detailed company insights
Cizzle Biotech is focused on developing a cost-effective and non-invasive blood test for the early detection of lung cancer, utilizing their proprietary CIZ1B biomarker technology. Their innovative solution aims to reduce reliance on CT scans, which often lead to false positives and unnecessary procedures. The company targets healthcare professiona... Read More
